StockRunway.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.
New York, NY -- (SBWIRE) -- 01/28/2014 -- StockRunway.com issues special report on: McEwen Mining Inc (NYSE:MUX), Magnum Hunter Resources Corp (NYSE:MHR), Arena Pharmaceuticals, Inc.(NASDAQ:ARNA), Pan American Silver Corp. (USA)(NASDAQ:PAAS)
McEwen Mining Inc (NYSE:MUX) opened its shares at the price of $2.62 for the day. Its closing price was $2.48 after losing -5.70% for the day. The company traded with the total volume of 3.07 million shares, while its average trading volume remained 2.54 million shares. The beta of MUX stands at -0.28. McEwen Mining Inc. is engaged in the exploration for, development of, production, and sale of gold, silver, and copper. The company’s principal assets consist of a 49% interest in the San José Mine in Santa Cruz, Argentina; the El Gallo complex in Sinaloa, Mexico.
Has MUX Found The Bottom and Ready To Move Up? Find Out Here
Magnum Hunter Resources Corp (NYSE:MHR) percentage change plunged -5.54% to close at $8.01 with the total traded volume of 4.86 million shares, and average volume of 4.30 million. The 52 week range of the stock remained $2.37 - $8.81, while its day lowest price was $7.81 and it hit its day highest price at $8.53. Magnum Hunter Resources Corporation, an independent oil and gas company, engages in the exploration, exploitation, acquisition, development, and production of crude oil, natural gas, and natural gas liquid resources in the United States and Canada.
Has MHR Found The Bottom And Ready To Gain Momentum? Find Out Here
Arena Pharmaceuticals, Inc.(NASDAQ:ARNA) started its trading session with the price of $7.38 and closed at $6.93 by scoring -5.33%. ARNA’s stocks traded with total volume of 7.90 million shares, while the average trading volume remained 5.49 million shares. The beta of ARNA stands at -0.40. Day range of the stock was $6.61 -$7.38. Arena Pharmaceuticals, Inc., a biopharmaceutical company, engages in discovering, developing, and commercializing novel drugs that target G protein-coupled receptors in the therapeutic areas of cardiovascular, central nervous system, inflammatory, and metabolic diseases.
Why Should Investors Buy ARNA After the Recent Fall? Just Go Here and Find Out
Pan American Silver Corp. (USA)(NASDAQ:PAAS) ended its day with the loss of -5.21% and closed at the price of $12.20 after opening at $12.68. Stock traded during its last trading session with the total volume of 2.55 million shares, as compared to its average volume of 1.94 million shares. Pan American Silver Corp. engages in the exploration, development, and operation of silver producing properties and assets. It produces and sells silver, gold, copper, lead, and zinc.
Will PAAS Get Buyers Even After The Recent Rally? Find Out Here
StockRunway.com is an Elite Financial Stock website catering to individual investors, fund managers, investment bankers and equity analysts. Whether you're new to penny stocks or a seasoned veteran, you'll find all the information you will need right here! Our research is a remarkable educational tool for everyone to utilize.
Sign up TODAY and join the vast amount of investors already benefiting from the best free alerts from StockRunway's service today!
This report/release/advertisement is a commercial advertisement and is for general information purposes only. Never invest in any stock featured on our site, Press Releases or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE WELL: StockRunway.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever. Read our Full Disclaimer by visiting our website.
Read Our Full Disclaimer at: http://www.stockrunway.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)